1-7 of 7
Junko Matsuzaki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3966: NK receptors enable TCR-mediated CTL recognition and killing of cancer cells expressing non-mutated tumor-associated antigens

Bowen Dong, Nataša Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy Bonura, Henry Withers, Mark Long, Colin Chavel, Scott H. Olejniczak, Hans Minderman, Robert P. Edwards, Walter J. Storkus, Pedro Romero, Pawel Kalinski
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3966.
https://doi.org/10.1158/1538-7445.AM2024-3966
Published: 22 March 2024
View article titled, Abstract 3966: NK receptors enable TCR-mediated CTL recognition and killing of cancer cells expressing non-mutated tumor-associated antigens
Journal Articles

Abstract 1983: Cancer exosomes immunosuppressive activity in the absence of contaminating soluble factors is multifactorial

Shin La Shu, Junko Matsuzaki, Cheryl Allen, Yunchen Yang, Edward Hurley, Kunle Odunsi, Yun Wu, Marc S. Ernstoff
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1983.
https://doi.org/10.1158/1538-7445.AM2019-1983
Published: 01 July 2019
View article titled, Abstract 1983: Cancer exosomes immunosuppressive activity in the absence of contaminating soluble factors is multifactorial
Journal Articles

Abstract LB-186: Sustained efficacy of immunotherapy for solid tumors with novel dual CD4/CD8 T cell receptor engineered synergistic combination of hematopoietic stem cells and T cells

Richard C. Koya, Thinle Chodon, Junko Matsuzaki, Takemasa Tsuji, Satoko Matsueda, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): LB-186.
https://doi.org/10.1158/1538-7445.AM2017-LB-186
Published: 01 July 2017
View article titled, Abstract LB-186: Sustained efficacy of immunotherapy for solid tumors with novel dual CD4/CD8 T cell receptor engineered synergistic combination of hematopoietic stem cells and T cells
Journal Articles

CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity

Nassima Redjimi, Caroline Raffin, Isabelle Raimbaud, Pascale Pignon, Junko Matsuzaki, Kunle Odunsi, Danila Valmori, Maha Ayyoub
Journal: Cancer Research
Cancer Res (2012) 72 (17): 4351–4360.
https://doi.org/10.1158/0008-5472.CAN-12-0579
Published: 30 August 2012
View article titled, CXCR3<sup>+</sup> T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
Open the PDF for CXCR3<sup>+</sup> T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity in another window
Includes: Supplementary data
Journal Articles

Abstract 5398: Direct interaction of inhibitory molecules LAG-3 and PD-1 in murine CD8+ T cell signaling

Ruea-Yea Huang, Cheryl Eppolito, Junko Matsuzaki, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 5398.
https://doi.org/10.1158/1538-7445.AM2012-5398
Published: 15 April 2012
View article titled, Abstract 5398: Direct interaction of inhibitory molecules LAG-3 and PD-1 in murine CD8+ T cell signaling
Journal Articles

Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer

Feng Qian, Jeannine Villella, Paul K. Wallace, Paulette Mhawech-Fauceglia, Joseph D. Tario, Jr., Christopher Andrews, Junko Matsuzaki, Danila Valmori, Maha Ayyoub, Peter J. Frederick, Amy Beck, Jianqun Liao, Richard Cheney, Kirsten Moysich, Shashikant Lele, Protul Shrikant, Lloyd J. Old, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2009) 69 (13): 5498–5504.
https://doi.org/10.1158/0008-5472.CAN-08-2106
Published: 01 July 2009
View article titled, Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer
Open the PDF for Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Potentiation of Tumor Eradication by Adoptive Immunotherapy with T-cell Receptor Gene-Transduced T-Helper Type 1 Cells

Kenji Chamoto, Takemasa Tsuji, Hiromi Funamoto, Akemi Kosaka, Junko Matsuzaki, Takeshi Sato, Hiroyuki Abe, Keishi Fujio, Kazuhiko Yamamoto, Toshio Kitamura, Tsuguhide Takeshima, Yuji Togashi, Takashi Nishimura
Journal: Cancer Research
Cancer Res (2004) 64 (1): 386–390.
https://doi.org/10.1158/0008-5472.CAN-03-2596
Published: 16 January 2004
View article titled, Potentiation of Tumor Eradication by Adoptive Immunotherapy with T-cell Receptor Gene-Transduced T-Helper Type 1 Cells
Open the PDF for Potentiation of Tumor Eradication by Adoptive Immunotherapy with T-cell Receptor Gene-Transduced T-Helper Type 1 Cells in another window